Refractory Germ Cell Tumors
Showing 1 - 25 of >10,000
Germ Cell Tumor, Seminoma, Non-seminomatous Germ Cell Tumor Trial in Indianapolis (Cabozantinib)
Recruiting
- Germ Cell Tumor
- +3 more
-
Indianapolis, IndianaIndiana University Melvin & Bren Simon Cancer Center
Nov 16, 2022
Germ Cell Tumors, Testicular Tumors, Non Seminomatous Germ Cell Tumors Trial in Indianapolis, Philadelphia (Pembrolizumab)
Terminated
- Germ Cell Neoplasms
- +6 more
-
Indianapolis, Indiana
- +1 more
Jul 7, 2022
Germ Cell Tumor, Nonseminomatous Germ Cell Tumor, Seminoma Trial in United States (Durvalumab, Tremelimumab)
Active, not recruiting
- Germ Cell Tumor
- +5 more
-
Basking Ridge, New Jersey
- +6 more
May 2, 2022
Incurable Platinum Refractory Germ Cell Tumors, Tumors Trial in Indianapolis, New York, Philadelphia (ASP1650)
Completed
- Incurable Platinum Refractory Germ Cell Tumors
- Tumors
-
Indianapolis, Indiana
- +2 more
Nov 30, 2021
CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (EGFR806-specific chimeric antigen receptor (CAR) T cell)
Active, not recruiting
- Central Nervous System Tumor, Pediatric
- +8 more
- EGFR806-specific chimeric antigen receptor (CAR) T cell
-
Seattle, WashingtonSeattle Children's Hospital
Jan 18, 2023
CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (HER2-specific chimeric antigen receptor (CAR) T cell)
Recruiting
- Central Nervous System Tumor, Pediatric
- +8 more
- HER2-specific chimeric antigen receptor (CAR) T cell
-
Seattle, WashingtonSeattle Children's Hospital
Dec 14, 2022
Germ Cell Tumors, Measurable Disease Trial in Milano (Pazopanib)
Completed
- Germ Cell Tumors
- Measurable Disease
-
Milano, Mi, ItalyFondazione IRCCS Istituto Nazionale dei Tumori
May 12, 2021
Germ Cell Tumor Trial in Milano (Durvalumab, Tremelimumab)
Terminated
- Germ Cell Tumor
-
Milano, ItalyFondazione IRCCS Istituto Nazionale dei Tumori
May 12, 2021
Non-CNS Germ Cell Tumors (Seminomas and Nonseminomas) Trial in France, United Kingdom, United States (Tivantinib (ARQ 197))
Terminated
- Non-CNS Germ Cell Tumors (Seminomas and Nonseminomas)
- Tivantinib (ARQ 197)
-
Los Angeles, California
- +9 more
Mar 12, 2021
Ex Vivo Drug Sensitivity Testing and Mutation Profiling
Completed
- Recurrent Childhood Acute Myeloid Leukemia
- +13 more
-
Miami, FloridaNicklaus Children's Hospital
Jan 18, 2023
Ewing Sarcoma, Rhabdomyosarcoma, Wilms Tumor Trial in Valhalla (Vorinostat)
Recruiting
- Ewing Sarcoma
- +5 more
-
Valhalla, New YorkNew York Medical College
Oct 24, 2022
CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric
Recruiting
- Central Nervous System Tumor
- +10 more
- SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
-
Seattle, WashingtonSeattle Children's Hospital
Dec 14, 2022
Pediatric Cancer, Solid Tumors, Rhabdomyosarcoma Trial in Washington (Magnetic resonance high intensity focused ultrasound,
Recruiting
- Pediatric Cancer
- +9 more
- Magnetic resonance high intensity focused ultrasound
- Lyso-thermosensitive liposomal doxorubicin
-
Washington, District of ColumbiaChildren's National Medical Center
Dec 10, 2021
Relapsed Pediatric Solid Tumors, Refractory Pediatric Solid Tumors, Rhabdomyosarcoma Trial in Washington, Cincinnati (Magnetic
Active, not recruiting
- Relapsed Pediatric Solid Tumors
- +9 more
- Magnetic Resonance High Intensity Focused Ultrasound
-
Washington, District of Columbia
- +1 more
Jan 21, 2022
Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second
Recruiting
- Pediatric Solid Tumor
- +15 more
- second generation 4-1BBζ EGFR806-EGFRt
- second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
-
Seattle, WashingtonSeattle Children's Hospital
May 2, 2022
Germ Cell Tumor, Testis Cancer, Testicular Cancer Trial in Indianapolis (Guadecitabine (SGI-110))
Completed
- Germ Cell Tumor
- +2 more
- Guadecitabine (SGI-110)
-
Indianapolis, Indiana
- +1 more
Sep 22, 2020
Solid Tumors, Soft Tissue Sarcoma, Ewing Sarcoma Trial (Magnetic Resonance-Guided High Intensity Focused Ultrasound,
Not yet recruiting
- Solid Tumors
- +8 more
- Magnetic Resonance-Guided High Intensity Focused Ultrasound
- Lyso-thermosensitive Liposomal Doxorubicin
- (no location specified)
Mar 10, 2022
Genitourinary Cancer, Adrenocortical Carcinoma, Non-urothelial Bladder Trial in United States (Ipilimumab, Nivolumab)
Recruiting
- Genitourinary Cancer
- +7 more
-
La Jolla, California
- +5 more
Jul 5, 2022
Germ Cell Tumors of the Central Nervous System
Recruiting
- Germ Cell Tumor of CNS
-
Beijing, ChinaSanbo Brain Hospital Capital Medical University
Apr 19, 2023
Malignant Ovarian Germ Cell Tumors
Recruiting
- Fertility Issues
- observational study
-
Cairo, EgyptDepartment of Obstetrics & Gynecology
Jun 7, 2023
Testicular Germ Cell Tumor Trial in Saint-Petersburg (Orchofuniculectomy with simultaneous laparoscopic biopsy of the sentinel
Recruiting
- Testicular Germ Cell Tumor
- Orchofuniculectomy with simultaneous laparoscopic biopsy of the sentinel lymph node using indocyanine green dye with/without methylene blue dye.
- Radiopharmaceutical administration (Technetium/methylene blue)
-
Saint-Petersburg, Russian FederationFederal State Budgetary Institute N.N. Petrov National Medical R
Nov 10, 2023
MiRNA in Detecting Active Germ Cell Tumors in Early Suspected
Recruiting
- Malignant Testicular Germ Cell Tumor
- Non-Interventional Study
-
Los Angeles, California
- +1 more
Sep 28, 2023